Revelation Biosciences Stock Price on December 2, 2024
| REVB Stock | USD 0.95 0.19 25.00% |
If you're considering investing in Revelation Stock, it is important to understand the factors that can impact its price. As of today, the current price of Revelation Biosciences stands at 0.95, as last reported on the 3rd of December, with the highest price reaching 0.98 and the lowest price hitting 0.78 during the day. At this point, Revelation Biosciences is very risky. Revelation Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0176, which implies the firm had a 0.0176% return per unit of risk over the last 3 months. We have found thirty technical indicators for Revelation Biosciences, which you can use to evaluate the volatility of the company. Please check Revelation Biosciences' Risk Adjusted Performance of 0.0203, coefficient of variation of 6660.22, and Semi Deviation of 4.1 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
At present, Revelation Biosciences' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 240.1 K, whereas Total Stockholder Equity is forecasted to decline to about 6.3 M. . At present, Revelation Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.30, whereas Price Earnings Ratio is forecasted to decline to (29.90). Revelation Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Revelation |
Sharpe Ratio = 0.0176
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | REVB | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.15 actual daily | 54 54% of assets are less volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Revelation Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Revelation Biosciences by adding it to a well-diversified portfolio.
Price Book 1.2202 | Enterprise Value Ebitda (1.02) | Price Sales 2.8821 | Shares Float 4.3 M | Wall Street Target Price 12.75 |
Revelation Biosciences Main Headline on 2nd of December 2024
REVB Gets FDA Go Ahead by finance.yahoo.com
By Brad Sorensen, CFA NASDAQREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences announced that the FDA has accepted the companys IND application for Gemini. This announcement allows the Company to initiate its US based Phase 1b clinical study to evaluate the potential of Gemini as a preconditioning treatment in patients with chronic kidney disease . This is
Revelation Biosciences Valuation on December 2, 2024
It is possible to determine the worth of Revelation Biosciences on a given historical date. On December 2, 2024 Revelation was worth 0.86 at the beginning of the trading date compared to the closed value of 0.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Revelation Biosciences stock. Still, in general, we apply an absolute valuation method to find Revelation Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Revelation Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Revelation Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.76 | 0.78 | 0.75 | 0.76 | 31,050 | |
12/02/2024 | 0.86 | 0.98 | 0.78 | 0.95 | 12,634,508 |
| 0.86 | 0.98 | 0.78 | 0.95 | 0.00 |
| Backtest Revelation Biosciences | | | Revelation Biosciences History | | | Revelation Biosciences Valuation | Previous | Next |
Revelation Biosciences Trading Date Momentum on December 2, 2024
| On December 03 2024 Revelation Biosciences was traded for 0.95 at the closing time. The top price for the day was 0.98 and the lowest listed price was 0.78 . There was no trading activity during the period 0.0. Lack of trading volume on December 3, 2024 did not cause price change. The trading delta at closing time against the current closing price is 9.47% . |
Revelation Biosciences Fundamentals Correlations and Trends
By evaluating Revelation Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Revelation financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Revelation Biosciences Stock history
Revelation Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Revelation is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Revelation Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Revelation Biosciences stock prices may prove useful in developing a viable investing in Revelation Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 228.6 K | 240.1 K | |
| Net Loss | -1.9 M | -1.8 M |
Revelation Biosciences Stock Technical Analysis
Revelation Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Revelation Biosciences Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Revelation Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Revelation Biosciences December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Revelation Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revelation Biosciences shares will generate the highest return on investment. By undertsting and applying Revelation Biosciences stock market strength indicators, traders can identify Revelation Biosciences entry and exit signals to maximize returns
Revelation Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Revelation Biosciences' price direction in advance. Along with the technical and fundamental analysis of Revelation Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Revelation to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0203 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.87) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0496 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Revelation Stock analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |